Beyond 2010: Gaps, Challenges and Priorities for the Future of PrEP

From AIDS Research and Human Retroviruses, by Veronese, Turpin and Feuer

A workshop entitled Beyond 2010: Gaps, Challenges, and Priorities for the Future of Preclinical HIV Pre-Exposure Prophylaxis (PrEP) was sponsored by the Division of AIDS (DAIDS) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), on October 20-21, 2009, in Bethesda, Maryland.

The objective of the workshop was to identify the main gaps in current knowledge, challenges, and priorities for the establishment of a PrEP preclinical pipeline and to also provide guidance for future directions of the field and DAIDS activities in this area. This 2-day workshop, through various presentations and breakout group discussions, specifically addressed four main topics that will be critical in identifying and advancing the next generation of PrEP candidates for clinical testing. The topics were (1) drug discovery, (2) pharmacokinetics (PK) and pharmacodynamics (PD), (3) animal models, and (4) delivery systems for prologed activity.

Read more

Join IRMA in learning the basic science of drug discovery

via IRMA

Enhance your advocacy skills and bone up on some of the basics. Dr. Jim Turpin of the Microbicide Research Branch at the National Institutes of Health, National Institutes of Allergy and Infectious Diseases, will explain the basic science of drug discovery – the research that happens before we move on to Phase I safety testing in people. Many of us find basic science confusing, daunting, and scary. Jim will show us that it doesn’t have to be any of those things, and is in fact, fascinating!

Register for the Sep 29 teleconference now!

And check out  our slides and recordings from previous IRMA teleconferences here. Previous topics have included lube safety, the epidemiology of HIV among gay men in Africa,  putting pleasure back into prevention, and "the joy of stats."